We are live on ! Find out more
AICPI

ABG Innovation Capital Partners III Portfolio holdings

AUM $64.5K
1-Year Est. Return 1.01%
This Fund
S&P 500
This Quarter Est. Return
-44.86%
1 Year Est. Return
+1.01%
3 Year Est. Return
+5.56%
5 Year Est. Return
-85.52%
10 Year Est. Return
–
AUM
$1.34M
AUM Growth
-$119K
Cap. Flow
+$781K
Cap. Flow %
58.14%
Top 10 Hldgs %
100%
Holding
6
New
1
Increased
–
Reduced
–
Closed
–

Top Buys

1
CSTL icon
Castle Biosciences
CSTL
+$781K

Top Sells

No sells this quarter

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CSTL icon
1
Castle Biosciences
CSTL
$697M
$738K 54.91%
+33,626
New +$781K
WHWK
2
Whitehawk Therapeutics
WHWK
$190M
$329K 24.48%
26,666
– –
SYBX
3
DELISTED
Synlogic
SYBX
$237K 17.63%
13,727
– –
ACGN
4
DELISTED
Aceragen Inc
ACGN
$26K 1.93%
3,312
– –
NBRV
5
DELISTED
Nabriva Therapeutics plc Ordinary Shares Ireland
NBRV
$8K 0.6%
1,834
– –
GNCA
6
DELISTED
Genocea Biosciences, Inc.
GNCA
$6K 0.45%
375,000
– –

Similar funds

FFVM
Founders Fund VI Management San Francisco, California $45.8K AUM 58.63% 1-Year Est. Return
SNN
Shen Neil Nanpeng $36.3K AUM 179.45% 1-Year Est. Return
AC
Antara Capital New York $30.2K AUM 5.24% 1-Year Est. Return
MI
Motiv8 Investments Port St. Lucie, Florida $183K AUM 15.06% 1-Year Est. Return
FFVM
Founders Fund VII Management San Francisco, California $2.03M AUM 72.34% 1-Year Est. Return
FFVM
Founders Fund V Management San Francisco, California $2.16M AUM 77.37% 1-Year Est. Return
NA
Newport Asia San Francisco, California $2.21M AUM
IVSFI
IA Venture Strategies Fund II New York $4.08M AUM 174.71% 1-Year Est. Return